Emerging Europe
The Emerging Europe Pharma & Healthcare Insight service provides analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting pharma and healthcare markets across Central and Eastern Europe. The service includes access to the very latest analysis plus a searchable archive of articles and data.
› To gain FREE trial access for a limited period, click trial.
Turkey / Industry
BMI View: A key driver behind Turkey's continued double-digit growth in health expenditure is the country's improved health insurance coverage. The implementation of state-funded health insurance for the lowest earners will make a significant contribution to continued health expenditure growth over the next five years.
2010-09-01Greece / Industry
BMI View: The introduction of a new method to calculate drug prices in Greece will increase some drug prices and reduce others. The industry's reaction to the pricing method has so...
2010-08-27Bulgaria / Industry
BMI View: The outlook for pharmaceutical companies operating in Bulgaria is deteriorating. Disagreements between hospitals and the national funding bodies are a key concern for the...
2010-08-16Industry Developments
Turkey
BMI View: A key driver behind Turkey's continued double-digit growth in health expenditure is the country's improved health insurance coverage. The implementation of state-funded health...
2010-09-01Greece
BMI View: The introduction of a new method to calculate drug prices in Greece will increase some drug prices and reduce others. The industry's reaction to the pricing method has so...
2010-08-27Bulgaria
BMI View: The outlook for pharmaceutical companies operating in Bulgaria is deteriorating. Disagreements between hospitals and the national funding bodies are a key concern for the...
2010-08-16Romania
BMI View: While Romania's healthcare system faces immense challenges in the short to medium term, it is unlikely that the provision of medical services will collapse due to budget shortfalls,...
2010-08-11
